ANI製藥 ANIP 深 滬
已收盤 12-24 16:00:00 美东时间
82.18
+1.450
+1.80%
華盛通- 最 高82.3623
- 今 開80.73
- 成交量 19.99万股
- 最 低 80.42
- 昨 收 80.73
- 總市值 18.46亿
- 52周最高 99.50
- 市盈率 靜 --
- 換手率 0.89%
- 52周最低 52.735
- 委 比 -92.48%
- 總股本 2245.82万
- 歷史最高 99.50
- 量 比 0.36
- 振 幅 2.41%
- 歷史最低 0.80
- 每 手 1
- 風險率 13.92%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 花旗上调苹果目标价升至330美元；GPCR、KYMR、MAMA、TERN、WVE等获多家机构上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从12美元升至13美元；Guggenheim：维持Praxis Precision Medicine"买入"评级，目标价从540美元升至760美元
12-10 10:33
Barclays Initiates Coverage On ANI Pharmaceuticals with Overweight Rating, Announces Price Target of $100
Barclays analyst Glen Santangelo initiates coverage on ANI Pharmaceuticals (NASDAQ:ANIP) with a Overweight rating and announces Price Target of $100.
12-09 23:27
ANI Pharma Elects Thomas Haughey As Chairman Of The Board, Succeeding Patrick Walsh
ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (NASDAQ:ANIP) today announced that its Chairman, Patrick D. Walsh, will retire from the Company's Board of Directors after a distinguished tenure of service. His
12-01 19:53
ANI Pharmaceuticals Announces Board Transition
Patrick D. Walsh has retired as Chairman of ANI Pharmaceuticals, Inc., effective after the 2026 Annual Meeting. Thomas J. Haughey, a Board member since 2018, has been elected as the new Chairman. Walsh expressed pride in ANI's growth and confidence in the team's future. Haughey emphasized his commitment to supporting patients and delivering profitable growth. Jeanne Thoma will replace Haughey as Chair of the Audit and Finance Committee. This lead...
12-01 11:50
ANI Pharmaceuticals to Present at the Piper Sandler 37th Annual Healthcare Conference
ANI Pharmaceuticals CEO Nikhil Lalwani will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on December 2 at 2:00 p.m. ET. The event will be live-streamed and archived on the company’s website under the Investors section for 90 days. ANI, a biopharmaceutical company focused on rare diseases, generics, and brands, aims to deliver innovative therapeutics. For more details, visit their website. ANI Pharmaceutic...
11-25 11:50
ANI Pharmaceuticals to Present at the Jefferies Global Healthcare Conference – London
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced that CEO Nikhil Lalwani will participate in a fireside chat at the Jefferies Global Healthcare Conference – London on November 18 at 3:00 p.m. GMT/10:00 a.m. ET. The live and archived chat will be available on the Company’s website under the Investors section, with a 90-day replay. ANI is a biopharmaceutical company focused on innovative therapeutics across rare disease, generics, and brands busi...
11-11 21:05
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
11-11 10:49
Guggenheim Maintains Buy on ANI Pharmaceuticals, Raises Price Target to $115
Guggenheim analyst Vamil Divan maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and raises the price target from $114 to $115.
11-10 22:47
ANI Pharmaceuticals Highlights November 2025 Financial Strategies
ANI Pharmaceuticals ( ($ANIP) ) has shared an update. ANI Pharmaceuticals relea...
11-10 22:17
